Utilization of Early Invasive Management Strategies for High-Risk Patients With Non–ST-Segment Elevation Acute Coronary SyndromesDeepak L. Bhatt, for the CRUSADE Investigators, Matthew T. Roe et al.|JAMA|2004Cited by 572
Use of Evidence-Based Therapies in Short-Term Outcomes of ST-Segment Elevation Myocardial Infarction and Non–ST-Segment Elevation Myocardial Infarction in Patients With Chronic Kidney DiseaseCaroline S. Fox, Stephen D. Wiviott, Paul Muntner et al.|Circulation|2010Cited by 457
Prevalence, predictors, and outcomes of patients with non–ST-segment elevation myocardial infarction and insignificant coronary artery disease: Results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE) initiativeManesh R. Patel, Matthew T. Roe, Anita Y. Chen et al.|American Heart Journal|2006Cited by 214
The American Heart Association 2030 Impact Goal: A Presidential Advisory From the American Heart AssociationSonia Y. Angell, John J. Warner, Michael V. McConnell et al.|Circulation|2020Cited by 196
A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 TrialDominick J. Angiolillo, Mark B. Effron, J J Badimón et al.|European Heart Journal|2011Cited by 182